TUGOLVI

Serial Number 90278425
606

Registration Progress

Application Filed
Oct 26, 2020
Under Examination
Jun 8, 2021
Approved for Publication
Apr 13, 2021
Published for Opposition
Apr 13, 2021
Registered

Trademark Image

TUGOLVI

Basic Information

Serial Number
90278425
Filing Date
October 26, 2020
Published for Opposition
April 13, 2021
Abandonment Date
July 15, 2024
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jul 15, 2024
Classes
005

Rights Holder

JOHNSON & JOHNSON

03
Address
One Johnson & Johnson Plaza
New Brunswick, NJ 08933

Ownership History

JOHNSON & JOHNSON

Original Applicant
03
New Brunswick, NJ

JOHNSON & JOHNSON

Owner at Publication
03
New Brunswick, NJ

Legal Representation

Attorney
Cheryl Foytlin

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

31 events
Date Code Type Description Documents
Jul 15, 2024 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Jul 15, 2024 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Dec 5, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 4, 2023 EX5G S SOU EXTENSION 5 GRANTED Loading...
Dec 4, 2023 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Nov 21, 2023 EXT5 S SOU EXTENSION 5 FILED Loading...
Nov 21, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 3, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 1, 2023 EX4G S SOU EXTENSION 4 GRANTED Loading...
Jun 1, 2023 EXT4 S SOU EXTENSION 4 FILED Loading...
Jun 1, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 8, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 6, 2022 EX3G S SOU EXTENSION 3 GRANTED Loading...
Oct 6, 2022 EXT3 S SOU EXTENSION 3 FILED Loading...
Oct 6, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 9, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 7, 2022 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jun 7, 2022 EXT2 S SOU EXTENSION 2 FILED Loading...
Jun 7, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 4, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 2, 2021 EX1G S SOU EXTENSION 1 GRANTED Loading...
Dec 2, 2021 EXT1 S SOU EXTENSION 1 FILED Loading...
Dec 2, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 8, 2021 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Apr 13, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 13, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 24, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 11, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 9, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Dec 15, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 29, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives

Classification

International Classes
005